Literature DB >> 15818676

Reduction of arthritis severity in protease-activated receptor-deficient mice.

Yuan H Yang1, Pam Hall, Christopher B Little, Amanda J Fosang, Georgia Milenkovski, Leilani Santos, Jin Xue, Peter Tipping, Eric F Morand.   

Abstract

OBJECTIVE: Protease-activated receptor 1 (PAR-1) is the cell surface receptor for thrombin. It is unclear whether thrombin contributes to inflammation other than by effects on coagulation. We investigated the proinflammatory participation of PAR-1 in antigen-induced arthritis (AIA).
METHODS: Arthritis was induced by intraarticular injection of methylated bovine serum albumin (mBSA) in preimmunized PAR-1-deficient (PAR-1(-/-)) and wild-type (WT) mice. The disease was assessed after 7 days by histologic examination of knee joints after decalcification and Safranin O/toluidine blue staining. Serum levels of anti-mBSA IgG, interferon-gamma, and interleukin-4 (IL-4) were determined by enzyme-linked immunosorbent assay. T cell proliferation response was determined by measuring the incorporation of (3)H-thymidine. Cytokine messenger RNA (mRNA) expression was detected in synovial tissues and peritoneal cells by real-time polymerase chain reaction.
RESULTS: Arthritis severity was significantly reduced in PAR-1(-/-) mice compared with WT mice (P = 0.017). Analysis of individual aspects of joint histology revealed significant reductions in synovial exudates (P < 0.001), cartilage degradation (P < 0.01), and bone damage (P = 0.05) in PAR-1(-/-) mice. Synovial IL-1, IL-6, and matrix metalloproteinase 13 (MMP-13) mRNA was significantly reduced in PAR-1(-/-) mice. The titers of antigen-specific serum anti-mBSA total IgG, IgG1, and IgG2a were significantly reduced, and serum IL-4 was significantly increased in arthritic PAR-1(-/-) mice. In contrast, no difference was observed in antigen-induced T cell proliferation between PAR-1(-/-) and WT mice. In vitro, thrombin-induced (but not lipopolysaccharide-induced) IL-1, IL-6, and MMP-13 mRNA expression was significantly impaired in PAR-1(-/-) mice compared with WT controls.
CONCLUSION: These data demonstrate the requirement of PAR-1 for the expression of AIA, the development of an antigen-specific Ig response, thrombin-induced macrophage cytokine and MMP expression, and the inhibitory effect of PAR-1 on serum IL-4. We conclude that PAR-1 plays a significant role in this model of arthritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818676     DOI: 10.1002/art.21001

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

Review 2.  Novel aspects of fibrin(ogen) fragments during inflammation.

Authors:  Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski
Journal:  Mol Med       Date:  2011-01-04       Impact factor: 6.354

Review 3.  Protease-activated receptor 4: a critical participator in inflammatory response.

Authors:  Qiang Fu; Jing Cheng; Yebo Gao; Yonglei Zhang; Xiaobing Chen; Jianguo Xie
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

4.  Transglutaminase factor XIII promotes arthritis through mechanisms linked to inflammation and bone erosion.

Authors:  Harini Raghu; Carolina Cruz; Cheryl L Rewerts; Malinda D Frederick; Sherry Thornton; Eric S Mullins; Jonathan G Schoenecker; Jay L Degen; Matthew J Flick
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

Review 5.  Thrombomodulin and its role in inflammation.

Authors:  Edward M Conway
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

6.  The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A.

Authors:  Matthew J Flick; Anil K Chauhan; Malinda Frederick; Kathryn E Talmage; Keith W Kombrinck; Whitney Miller; Eric S Mullins; Joseph S Palumbo; Xunzhen Zheng; Naomi L Esmon; Charles T Esmon; Sherry Thornton; Ann Becker; Leslie A Pelc; Enrico Di Cera; Denisa D Wagner; Jay L Degen
Journal:  Blood       Date:  2011-03-24       Impact factor: 22.113

7.  Activation of PAR(2) receptors sensitizes primary afferents and causes leukocyte rolling and adherence in the rat knee joint.

Authors:  F A Russell; N Schuelert; V E Veldhoen; M D Hollenberg; J J McDougall
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

8.  Detection of Subclinical Arthritis in Mice by a Thrombin Receptor-Derived Imaging Agent.

Authors:  Beth Friedman; Michael A Whitney; Elamprakash N Savariar; Christa Caneda; Paul Steinbach; Qing Xiong; Dina V Hingorani; Jessica Crisp; Stephen R Adams; Michael Kenner; Csilla N Lippert; Quyen T Nguyen; Monica Guma; Roger Y Tsien; Maripat Corr
Journal:  Arthritis Rheumatol       Date:  2017-11-29       Impact factor: 10.995

Review 9.  Proteinases and their receptors in inflammatory arthritis: an overview.

Authors:  Katerina Oikonomopoulou; Eleftherios P Diamandis; Morley D Hollenberg; Vinod Chandran
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

Review 10.  Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer.

Authors:  Sarah M Eck; Jessica S Blackburn; Adam C Schmucker; Peter S Burrage; Constance E Brinckerhoff
Journal:  J Autoimmun       Date:  2009-10-01       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.